课题基金 / 基金详情

项目摘要

项目成果

PETER J DIDIER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Risk of encephalitis from West Nile virus (WNV) infection increases dramatically with age. Individuals suffering neuroinvasive illness have mortality rates of less than 4% if under the age of 70, after which rates rise to over 20%. Our collaborators at ONPRC challenged sixteen age rhesus macagues (17-30 yrs) and 9 adult Rhesus (6-9 yrs) with two does of virus (1 x 107 or 1 x 109 pfu/animal); some experiments included mosquito salivary gland extract (SGE) generated from the insectory at TNPRC. Additionally fifteen Cynomolgus monkeys were challenged after thymectomy and/or CD8 T cell depletion to test various levels of immunodeficiency. Animals remained clinically normal. No fever, change in appetite, or behavior was detected that could be attributed to WNV infection. Quantitative PCR of whole blood revealed discrete and short lived viremia; however infectious virus was never isolated. Analysis of innate immune response revealed a marked increase in monocytes and eosinophils (with SGE) between days 2 and 10 post infection. Additionally flow cytometric analysis of PBMC revealed increased proliferation of CD3- cells. With regard to adaptive immunity, an age-associated reduction in CD4+ T cell proliferation was found. Humoral responses developed and were detected in nearly all animals. The results suggest that non-human primates mount and maintain an effective innate defense to WNV challenge. This project ended in June, 2010 and results were published in December.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL PATHOLOGY CORE
  • 批准号:
    8358097
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    PETER J DIDIER
  • 依托单位:
ANATOMIC PATHOLOGY CORE
  • 批准号:
    8358098
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    PETER J DIDIER
  • 依托单位:
PRIMATE PATHOLOGY DATABASE COLLABORATIVE
  • 批准号:
    8358081
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    PETER J DIDIER
  • 依托单位:
PRIMATE PATHOLOGY DATABASE COLLABORATIVE
  • 批准号:
    8172978
  • 项目类别:
  • 资助金额:
    $6.18万
  • 财政年份:
    2010
  • 负责人:
    PETER J DIDIER
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: